My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 305

    1.

    Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

    Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group.

    Diabetes Care. 2008 May;31(5):845-51. Epub 2008 Jan 25.PMID: 18223031 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

    Viberti G, Kahn SE, Greene DA, Herman WH, Zinman B, Holman RR, Haffner SM, Levy D, Lachin JM, Berry RA, Heise MA, Jones NP, Freed MI.

    Diabetes Care. 2002 Oct;25(10):1737-43.PMID: 12351470 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

    Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group.

    N Engl J Med. 2006 Dec 7;355(23):2427-43. Epub 2006 Dec 4. Erratum in: N Engl J Med. 2007 Mar 29;356(13):1387-8. PMID: 17145742 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

    Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team.

    Lancet. 2009 Jun 20;373(9681):2125-35. Epub 2009 Jun 6.PMID: 19501900 [PubMed - indexed for MEDLINE]Related articles

    5.

    [ADOPT study: which first-line glucose-lowering oral medication in type 2 diabetes?]

    Scheen AJ.

    Rev Med Liege. 2007 Jan;62(1):48-52. French. PMID: 17343130 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes.

    Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE; the A Diabetes Outcome Progression Trial Study Group.

    J Clin Endocrinol Metab. 2009 Oct 29. [Epub ahead of print]PMID: 19875477 [PubMed - as supplied by publisher]Related articles

    7.

    Thiazolidinediones and fractures in men and women.

    Dormuth CR, Carney G, Carleton B, Bassett K, Wright JM.

    Arch Intern Med. 2009 Aug 10;169(15):1395-402.PMID: 19667303 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rosiglitazone for type 2 diabetes mellitus.

    Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006063. Review.PMID: 17636824 [PubMed - indexed for MEDLINE]Related articles

    9.

    Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

    Loke YK, Singh S, Furberg CD.

    CMAJ. 2009 Jan 6;180(1):32-9. Epub 2008 Dec 10.PMID: 19073651 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.

    Shearer AT, Bagust A, Ampudia-Blasco FJ, Martínez-Lage Alvarez B, Pérez Escolano I, París G.

    Pharmacoeconomics. 2006;24 Suppl 1:49-59. Review.PMID: 16800162 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.

    Krentz A.

    Diabetes Metab Res Rev. 2009 Feb;25(2):112-26. Review.PMID: 19219860 [PubMed - indexed for MEDLINE]Related articles

    13.

    Coronary heart disease outcomes in patients receiving antidiabetic agents.

    McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.

    Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):711-25.PMID: 17551989 [PubMed - indexed for MEDLINE]Related articles

    14.

    Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up.

    Fisman EZ, Tenenbaum A, Boyko V, Benderly M, Adler Y, Friedensohn A, Kohanovski M, Rotzak R, Schneider H, Behar S, Motro M.

    Clin Cardiol. 2001 Feb;24(2):151-8.PMID: 11460818 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rosiglitazone and myocardial infarction in patients previously prescribed metformin.

    Dormuth CR, Maclure M, Carney G, Schneeweiss S, Bassett K, Wright JM.

    PLoS One. 2009 Jun 27;4(6):e6080.PMID: 19562036 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.

    Bakris GL, Ruilope LM, McMorn SO, Weston WM, Heise MA, Freed MI, Porter LE.

    J Hypertens. 2006 Oct;24(10):2047-55.PMID: 16957566 [PubMed - indexed for MEDLINE]Related articles

    17.

    Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study.

    Monami M, Cresci B, Colombini A, Pala L, Balzi D, Gori F, Chiasserini V, Marchionni N, Rotella CM, Mannucci E.

    Diabetes Care. 2008 Feb;31(2):199-203. Epub 2007 Nov 16.PMID: 18024851 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.

    Stocker DJ, Taylor AJ, Langley RW, Jezior MR, Vigersky RA.

    Am Heart J. 2007 Mar;153(3):445.e1-6.PMID: 17307426 [PubMed - indexed for MEDLINE]Related articles

    19.

    Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.

    Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM, Bank AJ.

    Vasc Med. 2007 Nov;12(4):311-8.PMID: 18048467 [PubMed - indexed for MEDLINE]Related articles

    20.

    A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe.

    Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, Heise MA, Jones NP, O'Neill MC, Freed MI, Kahn SE, Herman WH; for the ADOPT Study Group.

    Diabet Med. 2006 Dec;23(12):1289-94.PMID: 17116177 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity